Moderna, Inc.

CAMBRIDGE, MA How do I update this listing?

Create Email Alert

Moderna is based out of Cambridge. Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases. The firm last filed a Form D notice of exempt offering of securities on 2016-08-24. The notice included securities offered of Equity

Contact Info

moderna, inc.
200 TECHNOLOGY SQUARE
CAMBRIDGE MA    02139

Business Phone: 6177146500
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2016-08-24 D BIOTECHNOLOGY Equity 599,999,992 451,369,079 148,630,913
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
STEPHANE BANCEL subscription required
    EXECUTIVE OFFICER DIRECTOR
NOUBAR AFEYAN subscription required
    DIRECTOR
LEE BABISS subscription required
    DIRECTOR
PETER HUTT subscription required
    DIRECTOR
ROBERT LANGER subscription required
    DIRECTOR
JOHN MENDLEIN subscription required
    DIRECTOR
ELIZABETH NABEL subscription required
    DIRECTOR
HENRI TERMEER subscription required
    DIRECTOR
STEPHEN HOGE subscription required
    EXECUTIVE OFFICER
LORENCE KIM subscription required
    EXECUTIVE OFFICER
JAMES R. KASINGER subscription required
    EXECUTIVE OFFICER

Elevate your investments